Helius stimulator study. Mutant E. coli. Fighting cancer. Shopping cycle.

The scholarly work of Concordia faculty and researchers informs and improves society on many issues that affect our daily lives. Visit the Research section to read news stories involving research at Concordia, or read the most recent items here:   

• An Accesswire release from Helius Medical Technologies announces the participation of the Concordia PERFORM research centre in a feasibility study of a Portable Neuromodulation Stimulator (PoNS) device, designed by Helius. The Canadian investigation of the PoNS device involves testing the new technology as a means of treating neurological symptoms of multiple sclerosis, notably by stimulating the cranial nerves found in the tongue to improve a patient's balance and gait. The announcement confirms the enrollment of the first three of fourteen subjects for the double-blind study. The release is picked up by BusinessWire, TheNewswire, 4-traders, Canadian Money, TMCnet, Stockwatch, Alpha Stox, baystreet.ca, Yahoo Canada,Yahoo UK, Herald Online, Medical Device Network and Fin Win.
• One News Page, Environment Guru and Spektrum (in German) are the latest to write about research involving two Concordians, post-doctoral fellow Ziad El-Hajj and professor emeritus of biology Elaine Newman, into how mutant E. coli cells may lead to a better understanding of how pathogens work.
• Clinica Space and WebNewswire reprise a report about Concordia research, led by associate professor of Biology Vladimir Titorenko, into the cancer-fighting potential of a naturally produced bile acid in the human liver. The study was published in the International Journal of Molecular Sciences.
• Research by marketing professor Gad Saad is mentioned in an article in Kurier (in German) about scientists studying how their ovulation may impact women's fashion consumer choices. 

 More Researchers in the news